Obesity surgery and gut-brain communication

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 106-119

  Berthoud, Hans Rudolf ^a   Shin, Andrew C ^a   Zheng, Huiyuan ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Amylin; Bariatric surgery; Energy homeostasis; Ghrelin; GLP 1; Glucose homeostasis; Insulin; Metabolic syndrome; PYY; Roux en Y gastric bypass; Satiation; Type 2 diabetes; Vagus nerve

Indexed keywords

APOLIPOPROTEIN A4; CHOLECYSTOKININ RECEPTOR; GHRELIN; GHRELIN O ACYL TRANSFERASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; N ACETYLPHOSPHATIDYLETHANOLAMIDE; N OLEOYLETHANOLAMINE; PEPTIDE YY; PHOSPHOLIPID; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; AUTONOMIC INNERVATION; BODY FAT DISTRIBUTION; BODY WEIGHT; BRAIN FUNCTION; CALORIC INTAKE; CLINICAL EFFECTIVENESS; DIGESTION; EATING HABIT; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; FOOD PREFERENCE; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INSULIN RELEASE; INTESTINE FUNCTION; MACRONUTRIENT; MOTOR NERVE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SENSORY NERVE; STOMACH BYPASS; WEIGHT REDUCTION;

ANIMALS; BARIATRIC SURGERY; BRAIN; ENERGY METABOLISM; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; OBESITY; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 80053453262     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.01.023     Document Type: Article

References (185)

1. Li C., Ford E.S., McGuire L.C., Mokdad A.H. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 2007, 15(1):216-224.
2. Koopmans H.S. Internal signals cause large changes in food intake in one-way crossed intestines rats. Brain Res Bull 1985, 14(6):595-603.
3. Koopmans H.S. An integrated organismic response to lower gut stimulation. Scand J Gastroenterol Suppl 1983, 82:143-153.
4. Koopmans H.S., Sclafani A. Control of body weight by lower gut signals. Int J Obes 1981, 5(5):491-495.
5. Koopmans H.S., Sclafani A., Fichtner C., Aravich P.F. The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am J Clin Nutr 1982, 35(2):284-293.
6. Sclafani A., Koopmans H.S., Vasselli J.R., Reichman M. Effects of intestinal bypass surgery on appetite, food intake, and body weight in obese and lean rats. Am J Physiol 1978, 234(4):E389-E398.
7. Leibel R.L., Rosenbaum M., Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995, 332(10):621-628.
8. Froidevaux F., Schutz Y., Christin L., Jequier E. Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period. Am J Clin Nutr 1993, 57(1):35-42.
9. Schwartz A., Doucet E. Relative changes in resting energy expenditure during weight loss: a systematic review. Obes Rev 2010, 11(7):531-547.
10. Redman L.M., Heilbronn L.K., Martin C.K., de Jonge L., Williamson D.A., Delany J.P., et al. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS ONE 2009, 4(2):e4377.
11. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009, 122(3):248-256. e5.
12. Meguid M.M., Ramos E.J., Suzuki S., Xu Y., George Z.M., Das U.N., et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg 2004, 8(5):621-630.
13. Zheng H., Shin A.C., Lenard N.R., Townsend R.L., Patterson L.M., Sigalet D.L., et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 2009, 297(5):R1273-R1282.
14. Sjostrom L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Lifestyle, diabetes, and cardiovascular risk factors 10years after bariatric surgery. N Engl J Med 2004, 351(26):2683-2693.
15. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J, Toure M, Tschop M, Woods SC, Seeley RJ. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010;138 (7):2426-36, 2436 e1-3.
16. Nadreau E., Baraboi E.D., Samson P., Blouin A., Hould F.S., Marceau P., et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond) 2006, 30(3):419-429.
17. Chaston T.B., Dixon J.B., O'Brien P.E. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) 2007, 31(5):743-750.
18. Savastano S., Di Somma C., Angrisani L., Orio F., Longobardi S., Lombardi G., et al. Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study. J Clin Endocrinol Metab 2009, 94(3):817-826.
19. le Roux C.W., Aylwin S.J., Batterham R.L., Borg C.M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006, 243(1):108-114.
20. Guijarro A., Osei-Hyiaman D., Harvey-White J., Kunos G., Suzuki S., Nadtochiy S., et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg 2008, 247(5):779-790.
21. Suzuki S., Ramos E.J., Goncalves C.G., Chen C., Meguid M.M. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery 2005, 138(2):283-290.
22. Romanova I.V., Ramos E.J., Xu Y., Quinn R., Chen C., George Z.M., et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg 2004, 199(6):887-895.
23. Stylopoulos N., Hoppin A.G., Kaplan L.M. Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 2009, 17(10):1839-1847.
24. Guijarro A., Suzuki S., Chen C., Kirchner H., Middleton F.A., Nadtochiy S., et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 2007, 293(4):R1474-R1489.
25. Sugerman H.J., Kellum J.M., Engle K.M., Wolfe L., Starkey J.V., Birkenhauer R., et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992, 55(2 Suppl.):560S-566S.
26. Thirlby R.C., Bahiraei F., Randall J., Drewnoski A. Effect of Roux-en-Y gastric bypass on satiety and food likes: the role of genetics. J Gastrointest Surg 2006, 10(2):270-277.
27. Thomas J.R., Marcus E. High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass. Obes Surg 2008, 18(3):282-287.
28. Tichansky D.S., Boughter J.D., Madan A.K. Taste change after laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2006, 2(4):440-444.
29. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 2002, 51(Suppl. 1):i2-i5.
30. Berthoud H.R., Blackshaw L.A., Brookes S.J., Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004, 16(Suppl. 1):28-33.
31. Whitson B.A., Leslie D.B., Kellogg T.A., Maddaus M.A., Buchwald H., Billington C.J., et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res 2007, 142(2):295-300.
32. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., Magness S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 2010, 5(8):e12191.
33. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010, 299(2):G440-G448.
34. Bjorklund P., Laurenius A., Een E., Olbers T., Lonroth H., Fandriks L. Is the roux limb a determinant for meal size after gastric bypass surgery?. Obes Surg 2010, 20(10):1408-1414.
35. Burge J.C., Schaumburg J.Z., Choban P.S., DiSilvestro R.A., Flancbaum L. Changes in patients' taste acuity after Roux-en-Y gastric bypass for clinically severe obesity. J Am Diet Assoc 1995, 95(6):666-670.
36. Scruggs D.M., Buffington C., Cowan G.S. Taste acuity of the morbidly obese before and after gastric bypass surgery. Obes Surg 1994, 4(1):24-28.
37. Naslund E., Melin I., Gryback P., Hagg A., Hellstrom P.M., Jacobsson H., et al. Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr 1997, 66(1):26-32.
38. Olbers T., Bjorkman S., Lindroos A., Maleckas A., Lonn L., Sjostrom L., et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006, 244(5):715-722.
39. Berridge K.C. Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 2000, 24(2):173-198.
40. Bendsen N.T., Hother A.L., Jensen S.K., Lorenzen J.K., Astrup A. Effect of dairy calcium on fecal fat excretion: a randomized crossover trial. Int J Obes (Lond) 2008, 32(12):1816-1824.
41. Coles L.T., Moughan P.J., Awati A., Darragh A.J., Zou M.L. Predicted apparent digestion of energy-yielding nutrients differs between the upper and lower digestive tracts in rats and humans. J Nutr 2010, 140(3):469-476.
42. Hogan S., Fleury A., Hadvary P., Lengsfeld H., Meier M.K., Triscari J., et al. Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes 1987, 11(Suppl. 3):35-42.
43. Warne J.P., Padilla B.E., Horneman H.F., Ginsberg A.B., Pecoraro N.C., Akana S.F., et al. Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet. Ann Surg 2009, 249(2):269-276.
44. Bueter M., Lowenstein C., Olbers T., Wang M., Cluny N.L., Bloom S.R., et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010, 138(5):1845-1853.
45. Martin G.R., Beck P.L., Sigalet D.L. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol 2006, 12(26):4117-4129.
46. Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008, 87(5):1219-1223.
47. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
48. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15(13):1546-1558.
49. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031.
50. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009, 106(7):2365-2370.
51. Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59(12):3049-3057.
52. Carrasco F., Papapietro K., Csendes A., Salazar G., Echenique C., Lisboa C., et al. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg 2007, 17(5):608-616.
53. del Genio F., Alfonsi L., Marra M., Finelli C., del Genio G., Rossetti G., et al. Metabolic and nutritional status changes after 10% weight loss in severely obese patients treated with laparoscopic surgery vs integrated medical treatment. Obes Surg 2007, 17(12):1592-1598.
54. Das S.K., Roberts S.B., McCrory M.A., Hsu L.K., Shikora S.A., Kehayias J.J., et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am J Clin Nutr 2003, 78(1):22-30.
55. de Castro Cesar M., de Lima Montebelo M.I., Rasera I., de Oliveira A.V., Gomes Gonelli P.R., Aparecida Cardoso G. Effects of Roux-en-Y gastric bypass on resting energy expenditure in women. Obes Surg 2008, 18(11):1376-1380.
56. Tamboli R.A., Hossain H.A., Marks P.A., Eckhauser A.W., Rathmacher J.A., Phillips S.E., et al. Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 2010, 18(9):1718-1724.
57. Flancbaum L., Choban P.S., Bradley L.R., Burge J.C. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery 1997, 122(5):943-949.
58. Rodieux F., Giusti V., D'Alessio D.A., Suter M., Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008, 16(2):298-305.
59. Atkinson R.L., Brent E.L. Appetite suppressant activity in plasma of rats after intestinal bypass surgery. Am J Physiol 1982, 243(1):R60-R64.
60. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87(4):1409-1439.
61. Cummings D.E., Overduin J., Foster-Schubert K.E. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004, 89(6):2608-2615.
62. Bose M., Olivan B., Teixeira J., Pi-Sunyer F.X., Laferrere B. Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence?. Obes Surg 2009, 19(2):217-229.
63. Korner J., Inabnet W., Conwell I.M., Taveras C., Daud A., Olivero-Rivera L., et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006, 14(9):1553-1561.
64. Morinigo R., Moize V., Musri M., Lacy A.M., Navarro S., Marin J.L., et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006, 91(5):1735-1740.
65. Laferrere B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008, 93(7):2479-2485.
66. Laferrere B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., et al. Incretin levels and effect are markedly enhanced 1month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diab Care 2007, 30(7):1709-1716.
67. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007, 246(5):780-785.
68. Meirelles K., Ahmed T., Culnan D.M., Lynch C.J., Lang C.H., Cooney R.N. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg 2009, 249(2):277-285.
69. Shin A.C., Zheng H., Townsend R.L., Sigalet D.L., Berthoud H.R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010, 151(4):1588-1597.
70. Toft-Nielsen M.B., Madsbad S., Holst J.J. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diab Care 1999, 22(7):1137-1143.
71. Chelikani P.K., Haver A.C., Reidelberger R.D. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 2005, 288(6):R1695-R1706.
72. Talsania T., Anini Y., Siu S., Drucker D.J., Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146(9):3748-3756.
73. Ruttimann E.B., Arnold M., Hillebrand J.J., Geary N., Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009, 150(3):1174-1181.
74. Hayes M.R., Skibicka K.P., Grill H.J. Caudal brainstem processing is sufficient for behavioral, sympathetic and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocinology 2008, 149:4059-4068.
75. Batterham R.L., Heffron H., Kapoor S., Chivers J.E., Chandarana K., Herzog H., et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006, 4(3):223-233.
76. Roth C.L., Enriori P.J., Harz K., Woelfle J., Cowley M.A., Reinehr T. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. J Clin Endocrinol Metab 2005, 90(12):6386-6391.
77. le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147(1):3-8.
78. Korner J., Bessler M., Inabnet W., Taveras C., Holst J.J. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007, 3(6):597-601.
79. Holdstock C., Zethelius B., Sundbom M., Karlsson F.A., Eden Engstrom B. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond) 2008, 32(11):1640-1646.
80. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 2004, 110(1):36-43.
81. Berthoud H.R., Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat (Basel) 1996, 156(2):123-131.
82. D'Alessio D., Lu W., Sun W., Zheng S., Yang Q., Seeley R., et al. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system. Am J Physiol Regul Integr Comp Physiol 2007, 293(6):R2163-R2169.
83. Tang-Christensen M., Vrang N., Larsen P.J. Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes Relat Metab Disord 2001, 25(Suppl. 5):S42-S47.
84. Vrang N., Phifer C.B., Corkern M.M., Berthoud H.R. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am J Physiol Regul Integr Comp Physiol 2003, 285(2):R470-R478.
85. Vahl T.P., Tauchi M., Durler T.S., Elfers E.E., Fernandes T.M., Bitner R.D., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148(10):4965-4973.
86. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 1996, 271(5 Pt 1):E808-E813.
87. Tang-Christensen M., Larsen P.J., Goke R., Fink-Jensen A., Jessop D.S., Moller M., et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 1996, 271(4 Pt 2):R848-R856.
88. Sandoval D.A., Bagnol D., Woods S.C., D'Alessio D.A., Seeley R.J. Arcuate GLP-1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008, 106:455-463.
89. Ma X., Bruning J., Ashcroft F.M. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J Neurosci 2007, 27(27):7125-7129.
90. Yamamoto H., Kishi T., Lee C.E., Choi B.J., Fang H., Hollenberg A.N., et al. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 2003, 23(7):2939-2946.
91. Troy S., Soty M., Ribeiro L., Laval L., Migrenne S., Fioramonti X., et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008, 8(3):201-211.
92. Shin Y.K., Martin B., Golden E., Dotson C.D., Maudsley S., Kim W., et al. Modulation of taste sensitivity by GLP-1 signaling. J Neurochem 2008, 106:455-463.
93. Merchenthaler I., Lane M., Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999, 403(2):261-280.
94. Adams S.H., Lei C., Jodka C.M., Nikoulina S.E., Hoyt J.A., Gedulin B., et al. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J Nutr 2006, 136(1):195-201.
95. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346(21):1623-1630.
96. Fruhbeck G., Diez Caballero A., Gil M.J. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004, 350(3):308-309.
97. Tritos N.A., Mun E., Bertkau A., Grayson R., Maratos-Flier E., Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 2003, 11(8):919-924.
98. Korner J., Bessler M., Cirilo L.J., Conwell I.M., Daud A., Restuccia N.L., et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005, 90(1):359-365.
99. Stylopoulos N., Davis P., Pettit J.D., Rattner D.W., Kaplan L.M. Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats. Surg Endosc 2005, 19(7):942-946.
100. Stoeckli R., Chanda R., Langer I., Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004, 12(2):346-350.
101. Holdstock C., Engstrom B.E., Ohrvall M., Lind L., Sundbom M., Karlsson F.A. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003, 88(7):3177-3183.
102. Korner J., Inabnet W., Febres G., Conwell I.M., McMahon D.J., Salas R., et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009, 33(7):786-795.
103. Pournaras D.J., le Roux C.W. Ghrelin and metabolic surgery. Int J Pept 2010, 2010.
104. Sundbom M., Holdstock C., Engstrom B.E., Karlsson F.A. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality?. Obes Surg 2007, 17(3):304-310.
105. Williams D.L., Grill H.J., Cummings D.E., Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003, 144(12):5184-5187.
106. le Roux C.W., Neary N.M., Halsey T.J., Small C.J., Martinez-Isla A.M., Ghatei M.A., et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005, 90(8):4521-4524.
107. Heath R.B., Jones R., Frayn K.N., Robertson M.D. Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol 2004, 180(2):273-281.
108. Mundinger T.O., Cummings D.E., Taborsky G.J. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006, 147(6):2893-2901.
109. Hosoda H., Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept 2008, 146(1-3):12-18.
110. Zhao T.J., Sakata I., Li R.L., Liang G., Richardson J.A., Brown M.S., et al. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proc Natl Acad Sci USA 2010, 107(36):15868-15873.
111. Yokotani K., Wang M., Okada S., Murakami Y., Hirata M. Characterization of nicotinic acetylcholine receptor-mediated noradrenaline release from the isolated rat stomach. Eur J Pharmacol 2000, 402(3):223-229.
112. Yokotani K., Okada S., Murakami Y., Nakamura K. Nicotinic receptors involved in gastric noradrenaline release evoked by electrical stimulation of the splanchnic nerve in rats. Eur J Pharmacol 2001, 423(2-3):149-155.
113. McSwiney B.A., Robson J.M. The sympathetic innervation of the stomach: II. The effect of stimulation of the peri-arterial nerves on the stomach and small intestine. J Physiol 1931, 71(2):194-200.
114. Jacobowitz D. Histochemical studies of the autonomic innervation of the gut. J Pharmacol Exp Ther 1965, 149(3):358-364.
115. Barnett B.P., Hwang Y., Taylor M.S., Kirchner H., Pfluger P.T., Bernard V., et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010, 330(6011):1689-1692.
116. Romero A., Kirchner H., Heppner K., Pfluger P.T., Tschop M.H., Nogueiras R. GOAT: the master switch for the ghrelin system?. Eur J Endocrinol 2010, 163(1):1-8.
117. Kellum J.M., Kuemmerle J.F., O'Dorisio T.M., Rayford P., Martin D., Engle K., et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990, 211(6):763-770. discussion 770-1.
118. Naslund E., Gryback P., Hellstrom P.M., Jacobsson H., Holst J.J., Theodorsson E., et al. Gastrointestinal hormones and gastric emptying 20years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 1997, 21(5):387-392.
119. Glatzle J., Raybould H.E., Kueper M.A., Reeve J.R., Zittel T.T. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr Neurosci 2008, 11(2):69-74.
120. Rodriguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., et al. An anorexic lipid mediator regulated by feeding. Nature 2001, 414(6860):209-212.
121. Tso P., Liu M., John Kalogeris T., Thomson A.B. The role of apolipoprotein a-iv in the regulation of food intake. Annu Rev Nutr 2001, 21:231-254.
122. Gillum M.P., Zhang D., Zhang X.M., Erion D.M., Jamison R.A., Choi C., et al. N-acylphosphatidylethanolamine, a gut-derived circulating factor induced by fat ingestion, inhibits food intake. Cell 2008, 135(5):813-824.
123. Culnan D.M., Cooney R.N., Stanley B., Lynch C.J. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring) 2009, 17(1):46-52.
124. Campolongo P., Roozendaal B., Trezza V., Cuomo V., Astarita G., Fu J., et al. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci USA 2009, 106(19):8027-8031.
125. Gaetani S., Fu J., Cassano T., Dipasquale P., Romano A., Righetti L., et al. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 2010, 30(24):8096-8101.
126. Schwartz G.J., Fu J., Astarita G., Li X., Gaetani S., Campolongo P., et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 2008, 8(4):281-288.
127. Gaetani S., Kaye W.H., Cuomo V., Piomelli D. Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord 2008, 13(3):e42-e48.
128. Tourino C., Oveisi F., Lockney J., Piomelli D., Maldonado R. FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes (Lond) 2010, 34(3):557-568.
129. Mithieux G., Misery P., Magnan C., Pillot B., Gautier-Stein A., Bernard C., et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2005, 2(5):321-329.
130. Patti M.E., Houten S.M., Bianco A.C., Bernier R., Larsen P.R., Holst J.J., et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009, 17(9):1671-1677.
131. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439(7075):484-489.
132. Katsuma S., Hirasawa A., Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005, 329(1):386-390.
133. Roberts R.E., Glicksman C., Alaghband-Zadeh J., Sherwood R.A., Akuji N., le Roux C.W. The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol (Oxf) 2010, 74(1):67-72.
134. Mack C., Wilson J., Athanacio J., Reynolds J., Laugero K., Guss S., et al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 2007, 293(5):R1855-R1863.
135. Lutz T.A. Control of food intake and energy expenditure by amylin-therapeutic implications. Int J Obes (Lond) 2009, 33(Suppl. 1):S24-S27.
136. Roth J.D., Roland B.L., Cole R.L., Trevaskis J.L., Weyer C., Koda J.E., et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 2008, 105(20):7257-7262.
137. Roth J.D., Coffey T., Jodka C.M., Maier H., Athanacio J.R., Mack C.M., et al. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology 2007, 148(12):6054-6061.
138. Schauer P.R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238(4):467-484. discussion 84-5.
139. Wickremesekera K., Miller G., Naotunne T.D., Knowles G., Stubbs R.S. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005, 15(4):474-481.
140. Ali M.R., Fuller W.D., Rasmussen J. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2009, 5(3):346-351.
141. Cummings D.E. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009, 33(Suppl. 1):S33-S40.
142. Moo T.A., Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2008, 15(2):153-158.
143. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diab Care 2008, 31(Suppl. 2):S290-S296.
144. Holst J.J. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994, 107(6):1848-1855.
145. Kressel M., Berthoud H.R., Neuhuber W.L. Vagal innervation of the rat pylorus: an anterograde tracing study using carbocyanine dyes and laser scanning confocal microscopy. Cell Tissue Res 1994, 275(1):109-123.
146. Berthoud H.R., Carlson N.R., Powley T.L. Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol 1991, 260(1 Pt 2):R200-R207.
147. Berthoud H.R., Fox E.A., Powley T.L. Localization of vagal preganglionics that stimulate insulin and glucagon secretion. Am J Physiol 1990, 258(1 Pt 2):R160-R168.
148. Berthoud H.R., Powley T.L. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990, 258(2 Pt 2):R523-R530.
149. Stavney L.S., Kato T., Griffith C.A., Nyhus L.M., Harkins H.N. A physiologic study of motility changes following selective gastric vagotomy. J Surg Res 1963, 23:390-394.
150. Berthoud H.R., Fox E.A., Powley T.L. Abdominal pathways and central origin of rat vagal fibers that stimulate gastric acid. Gastroenterology 1991, 100(3):627-637.
151. Bueter M., Lowenstein C., Ashrafian H., Hillebrand J., Bloom S.R., Olbers T., et al. Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 2010, 20(5):616-622.
152. Schwartz G.J., Salorio C.F., Skoglund C., Moran T.H. Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression. Am J Physiol 1999, 276(6 Pt 2):R1623-R1629.
153. Phillips R.J., Powley T.L. Gastric volume detection after selective vagotomies in rats. Am J Physiol 1998, 274(6 Pt 2):R1626-R1638.
154. Berthoud H.-R. The caudal brainstem and the control of food intake and energy balance. Handbook of behavioral neurobiology 2004, Volume 14:195-240. Plenum, New York.
155. Berthoud H.R., Neuhuber W.L. Distribution and morphology of vagal afferents supplying the digestive system 1994, 43-66. CRC Press, Boca Raton. Y. Tache, D.L. Wingate, T.F. Burks (Eds.).
156. Berthoud H.R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000, 85(1-3):1-17.
157. Berthoud H.R., Kressel M., Neuhuber W.L. An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat Embryol (Berl) 1992, 186(5):431-442.
158. Shin AC ZH, Berthoud HR. Vagal innervation of portal hepatic vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism. Ann Surg in press.
159. Wang P.Y., Caspi L., Lam C.K., Chari M., Li X., Light P.E., et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008, 452(7190):1012-1016.
160. German J., Kim F., Schwartz G.J., Havel P.J., Rhodes C.J., Schwartz M.W., et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009, 150(10):4502-4511.
161. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123(4):1120-1128.
162. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005, 146(5):2369-2375.
163. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044(1):127-131.
164. Berthoud H.R., Kressel M., Raybould H.E., Neuhuber W.L. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol (Berl) 1995, 191(3):203-212.
165. Cox J.E., Kelm G.R., Meller S.T., Spraggins D.S., Randich A. Truncal and hepatic vagotomy reduce suppression of feeding by jejunal lipid infusions. Physiol Behav 2004, 81(1):29-36.
166. Wang F.B., Powley T.L. Topographic inventories of vagal afferents in gastrointestinal muscle. J Comp Neurol 2000, 421(3):302-324.
167. Zittel T.T., Lloyd K.C., Rothenhofer I., Wong H., Walsh J.H., Raybould H.E. Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat. Surgery 1998, 123(5):518-527.
168. Sclafani A., Ackroff K., Schwartz G.J. Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients. Physiol Behav 2003, 78(2):285-294.
169. Anil M.H., Forbes J.M. The roles of hepatic nerves in the reduction of food intake as a consequence of intraportal sodium propionate administration in sheep. Q J Exp Physiol 1988, 73(4):539-546.
170. Deutsch J.A., Jang Ahn S. The splanchnic nerve and food intake regulation. Behav Neural Biol 1986, 45(1):43-47.
171. Kelly L., Morales S., Smith B.K., Berthoud H.R. Capsaicin-treated rats permanently overingest low- but not high-concentration sucrose solutions. Am J Physiol Regul Integr Comp Physiol 2000, 279(5):R1805-R1812.
172. Powley T.L., Chi M.M., Baronowsky E.A., Phillips R.J. Gastrointestinal tract innervation of the mouse: afferent regeneration and meal patterning after vagotomy. Am J Physiol Regul Integr Comp Physiol 2005, 289(2):R563-R574.
173. Niijima A. Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 1982, 332:315-323.
174. Schwartz G.J., McHugh P.R., Moran T.H. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 1993, 265(4 Pt 2):R872-R876.
175. van den Hoek A.M., van Heijningen C., Schroder-van der Elst J.P., Ouwens D.M., Havekes L.M., Romijn J.A., et al. Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes 2008, 57(9):2304-2310.
176. Berthoud H.R., Hennig G., Campbell M., Volaufova J., Costa M. Video-based spatio-temporal maps for analysis of gastric motility in vitro: effects of vagal stimulation in guinea-pigs. Neurogastroenterol Motil 2002, 14(6):677-688.
177. Berthoud H.R., Powley T.L. Characteristics of gastric and pancreatic responses to vagal stimulation with varied frequencies: evidence for different fiber calibers?. J Auton Nerv Syst 1987, 19(1):77-84.
178. Trimble E.R., Berthoud H.R., Siegel E.G., Jeanrenaud B., Renold A.E. Importance of cholinergic innervation of the pancreas for glucose tolerance in the rat. Am J Physiol 1981, 241(5):E337-E341.
179. Siegel E.G., Trimble E.R., Renold A.E., Berthoud H.R. Importance of preabsorptive insulin release on oral glucose tolerance: studies in pancreatic islet transplanted rats. Gut 1980, 21(11):1002-1009.
180. Polyzogopoulou E.V., Kalfarentzos F., Vagenakis A.G., Alexandrides T.K. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003, 52(5):1098-1103.
181. Berthoud H.R., Powley T.L. Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil. Brain Res 1991, 553(2):336-341.
182. Berthoud H.R., Bereiter D.A., Trimble E.R., Siegel E.G., Jeanrenaud B. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 1981, 20:393-401. Suppl.
183. Wang J., Zheng H., Berthoud H.R. Functional vagal input to chemically identified neurons in pancreatic ganglia as revealed by Fos expression. Am J Physiol 1999, 277(5 Pt 1):E958-E964.
184. Berthoud H.R., Trimble E.R., Moody A.J. Lack of gastric inhibitory polypeptide (GIP) response to vagal stimulation in the rat. Peptides 1982, 3(6):907-912.
185. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999, 140(4):1687-1694.